1. Home
  2. WVE vs KRNT Comparison

WVE vs KRNT Comparison

Compare WVE & KRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • KRNT
  • Stock Information
  • Founded
  • WVE 2012
  • KRNT 2002
  • Country
  • WVE Singapore
  • KRNT Israel
  • Employees
  • WVE N/A
  • KRNT N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • KRNT Industrial Machinery/Components
  • Sector
  • WVE Health Care
  • KRNT Industrials
  • Exchange
  • WVE Nasdaq
  • KRNT Nasdaq
  • Market Cap
  • WVE 939.3M
  • KRNT 875.0M
  • IPO Year
  • WVE 2015
  • KRNT 2015
  • Fundamental
  • Price
  • WVE $6.54
  • KRNT $19.18
  • Analyst Decision
  • WVE Strong Buy
  • KRNT Strong Buy
  • Analyst Count
  • WVE 11
  • KRNT 5
  • Target Price
  • WVE $20.91
  • KRNT $32.80
  • AVG Volume (30 Days)
  • WVE 1.7M
  • KRNT 188.4K
  • Earning Date
  • WVE 05-08-2025
  • KRNT 05-14-2025
  • Dividend Yield
  • WVE N/A
  • KRNT N/A
  • EPS Growth
  • WVE N/A
  • KRNT N/A
  • EPS
  • WVE N/A
  • KRNT N/A
  • Revenue
  • WVE $104,939,000.00
  • KRNT $203,825,000.00
  • Revenue This Year
  • WVE N/A
  • KRNT $9.72
  • Revenue Next Year
  • WVE N/A
  • KRNT $12.05
  • P/E Ratio
  • WVE N/A
  • KRNT N/A
  • Revenue Growth
  • WVE N/A
  • KRNT N/A
  • 52 Week Low
  • WVE $4.25
  • KRNT $13.59
  • 52 Week High
  • WVE $16.74
  • KRNT $34.29
  • Technical
  • Relative Strength Index (RSI)
  • WVE 42.23
  • KRNT 50.66
  • Support Level
  • WVE $6.30
  • KRNT $18.16
  • Resistance Level
  • WVE $8.39
  • KRNT $19.68
  • Average True Range (ATR)
  • WVE 0.66
  • KRNT 0.86
  • MACD
  • WVE 0.10
  • KRNT 0.24
  • Stochastic Oscillator
  • WVE 33.21
  • KRNT 80.00

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

Share on Social Networks: